电针加穴位注射为主治疗术后早期炎性肠梗阻临床观察

Clinical observation on electroacupuncture combined with acupoint injection for treatment of early postoperative inflammatory intestinal obstruction

目的:探寻治疗术后早期炎性肠梗阻(EPISBO)的较佳疗法。方法:按入院先后顺序将240例患者分为4组,每组60例。A组予以西医常规治疗,包括胃肠减压、肠外营养、抗感染及支持疗法;B组在A组治疗基础上加电针治疗,穴取足三里、上巨虚等;C组在A组治疗基础上加穴位注射新斯的明,穴取大肠俞、足三里等;D组在A组治疗基础上加用电针(同B组)、穴位注射(同C组)治疗。结果:A组、B组、C组、D组总有效率分别为93.3%、96.7%、100.0%、100.0%,4组患者总有效率差异没有统计学意义(P>0.05)。A组、B组、C组、D组平均肠鸣音恢复时间分别为(11.5±2.9)天、(9.3±2.5)天、(5.6±3.5)天、(2.2±1.7)天,平均肛门排气时间分别为(12.5±3.1)天、(10.7±3.6)天、(7.2±3.1)天、(2.5±1.5)天,D组明显优于A、B、C组(均P<0.01)。结论:应用电针加穴位注射为主治疗EPISBO效果满意。

Objective To search for a better therapy for early postoperative inflammatory small bowel obstruction （EPISBO）. Methods Two hundred and forty cases were divided into four groups according to admitting order, 60 cases in each group. Routine treatments in western medicine were used in group A including gastrointestinal de- compression, parenteral nutrition, anti infection, supportive therapy and so on. Group B was treated with electroacupuncture in Zusanli （ST 36）, Shangjuxu （ST 37） etc. in addition to those given in group A. Group C was treated with acupoint injection with Neostigmine in Dachangshu （BL 25）, Zusanli （ST 36） etc. in addition to the treatment used in group A. Group I3 was treated with all of the treatments used in group A, B and C. Results The total ef fective rate was 93.3% in group A, 96.70% in group B, 100.0% in group C and group D. There was no significant difference among the four groups （P〉0.05）. The average recovery time of bowel sound was （11.5±2.9） days in group A, （9.3±2.5） days in groupB, （5.6±3.5） days in groupCand （2.2±1.7） days in group D. The average anal exsufflation time was （12.5±3. 1） days in group A, （10.7±3. 6） days in group B, （7.2±3. 1） days in group C and （2.5±1.5） days in group D. Group D was superior to those of other three groups obviously, and there were significant differences between them （all P〈0.01）. Conclusion Electroacupuncture combined with aeupoint injec- tion has a satisfied therapeutic effect for treatment of EPlSBO.